Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity TRVI - Trevi Therapeutics, Inc.
89.4 M
LAST VALUE
52.44%
2 YEAR CAGR
34.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR